
Metsep-P 2mg/500mg/15mg Tablet
Marketer
Sepik Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metsep-P 2mg/500mg/15mg Tablet
Glycemia-Trol 2mg/500mg/15mg tablets combine medications to manage blood glucose. This treatment, alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, reducing blood sugar. Dosage and duration for Glycemia-Trol 2mg/500mg/15mg tablets should follow your physician's instructions. Take with food to minimize stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, skip the missed dose. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk. Regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fracture, and respiratory infections. Prior to use, inform your doctor of any kidney, liver, or heart conditions. Pregnant or breastfeeding individuals require medical consultation before use. Kidney function tests will be assessed before treatment commences. Limit alcohol consumption as it may intensify side effects.
Uses of Metsep-P 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Metsep-P 2mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metsep-P 2mg/500mg/15mg Tablet should be administered with a meal.
Common Side effects of Metsep-P 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metsep-P 2mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Metsep-P 2mg/500mg/15mg Tablet should be administered with a meal.
How Metsep-P 2mg/500mg/15mg Tablet works:
Metsep-P 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Metsep-P 2mg/500mg/15mg tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Metsep-P 2mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Metsep-P 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms manifest.
KidneyCAUTION
Patients with kidney impairment should use Metsep-P 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. For individuals with severe kidney disease, Metsep-P 2mg/500mg/15mg tablets are contraindicated. Routine monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Metsep-P 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Metsep-P 2mg/500mg/15mg tablets are contraindicated for individuals with severe hepatic dysfunction.
What if you forget to take Metsep-P 2mg/500mg/15mg Tablet :
Should you forget to take your Metsep-P 2mg/500mg/15mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metsep-P 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
